This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Wang LY, Liang DC, Liu HC, et al. Alloimmunization among patients with transfusion-dependent thalassemia in Taiwan. Transfus Med 2006;16:200–3.WangLYLiangDCLiuHC,Alloimmunization among patients with transfusion-dependent thalassemia in Taiwan.2006;16:200–3.10.1111/j.1365-3148.2006.00656.x16764599Search in Google Scholar
Zaidi U, Borhany M, Ansari S, et al. Red cell alloimmunisation in regularly transfused beta thalassemia patients in Pakistan. Transfus Med 2015;25:106–10.ZaidiUBorhanyMAnsariS,Red cell alloimmunisation in regularly transfused beta thalassemia patients in Pakistan.2015;25:106–10.10.1111/tme.1219625870030Search in Google Scholar
Elhence P, Solanki A, Verma A. Red blood cell antibodies in thalassemia patients in northern India: risk factors and literature review. Indian J Hematol Blood Transfus 2014;30:301–8.ElhencePSolankiAVermaA.Red blood cell antibodies in thalassemia patients in northern India: risk factors and literature review.2014;30:301–8.10.1007/s12288-013-0311-y424340225435732Search in Google Scholar
Spanos T, Karageorga M, Ladis V, Peristeri J, Hatziliami A, Kattamis C. Red cell alloantibodies in patients with thalassemia. Vox Sang 1990;58:50–5.SpanosTKarageorgaMLadisVPeristeriJHatziliamiAKattamisC.Red cell alloantibodies in patients with thalassemia.1990;58:50–5.10.1111/j.1423-0410.1990.tb02055.x2316211Search in Google Scholar
Al-Riyami AZ, Al-Muqbali A, Al-Sudiri S, et al. Risks of red blood cell alloimmunization in transfusion-dependent beta-thalassemia in Oman: a 25-year experience of a university tertiary care reference center and a literature review. Transfusion 2018;58:871–8.Al-RiyamiAZAl-MuqbaliAAl-SudiriS,Risks of red blood cell alloimmunization in transfusion-dependent beta-thalassemia in Oman: a 25-year experience of a university tertiary care reference center and a literature review.2018;58:871–8.10.1111/trf.1450829399805Search in Google Scholar
Abdelrazik AM, Elshafie SM, El Said MN, et al. Study of red blood cell alloimmunization risk factors in multiply transfused thalassemia patients: role in improving thalassemia transfusion practice in Fayoum, Egypt. Transfusion 2016;56: 2303–7.AbdelrazikAMElshafieSMEl SaidMN,Study of red blood cell alloimmunization risk factors in multiply transfused thalassemia patients: role in improving thalassemia transfusion practice in Fayoum, Egypt.2016;56:2303–7.10.1111/trf.1369527351342Search in Google Scholar
Fucharoen S, Taphaichitr VS, Torcharus K, Viprakasit V. Clinical practice guidelines for diagnosis and management of thalassemia symdromes (in Thai). Bangkok, Thailand: P.A. Living, 2014.FucharoenSTaphaichitrVSTorcharusKViprakasitV..Bangkok, Thailand:P.A. Living,2014.Search in Google Scholar
Fasano RM, Chou ST. Red blood cell antigen genotyping for sickle cell disease, thalassemia, and other transfusion complications. Transfus Med Rev 2016;30:197–201.FasanoRMChouST.Red blood cell antigen genotyping for sickle cell disease, thalassemia, and other transfusion complications.2016;30:197–201.10.1016/j.tmrv.2016.05.01127345938Search in Google Scholar
Dhawan HK, Kumawat V, Marwaha N, et al. Alloimmunization and autoimmunization in transfusion dependent thalassemia major patients: study on 319 patients. Asian J Transfus Sci 2014;8:84–8.DhawanHKKumawatVMarwahaN,Alloimmunization and autoimmunization in transfusion dependent thalassemia major patients: study on 319 patients.2014;8:84–8.10.4103/0973-6247.137438414006925161344Search in Google Scholar
Thedsawad A, Taka O, Wanachiwanawin W. Prevalence and clinical significances of red cell alloimmunization and red cell bound immunoglobulin G in polytransfused patients with thalassemias. Hematology (Amsterdam, Netherlands) 2019;24:208–14.ThedsawadATakaOWanachiwanawinW.Prevalence and clinical significances of red cell alloimmunization and red cell bound immunoglobulin G in polytransfused patients with thalassemias.2019;24:208–14.10.1080/16078454.2018.154981830479186Search in Google Scholar
Singer ST, Wu V, Mignacca R, Kuypers FA, Morel P, Vichinsky EP. Alloimmunization and erythrocyte autoimmunization in transfusion-dependent thalassemia patients of predominantly Asian descent. Blood 2000;96:3369–73.SingerSTWuVMignaccaRKuypersFAMorelPVichinskyEP.Alloimmunization and erythrocyte autoimmunization in transfusion-dependent thalassemia patients of predominantly Asian descent.2000;96:3369–73.10.1182/blood.V96.10.3369Search in Google Scholar
Ameen R, Al-Shemmari S, Al-Humood S, Chowdhury RI, Al-Eyaadi O, Al-Bashir A. RBC alloimmunization and autoimmunization among transfusion-dependent Arab thalassemia patients. Transfusion 2003;43:1604–10.AmeenRAl-ShemmariSAl-HumoodSChowdhuryRIAl-EyaadiOAl-BashirA.RBC alloimmunization and autoimmunization among transfusion-dependent Arab thalassemia patients.2003;43:1604–10.10.1046/j.1537-2995.2003.00549.x14617321Search in Google Scholar
Pahuja S, Pujani M, Gupta SK, Chandra J, Jain M. Alloimmunization and red cell autoimmunization in multitransfused thalassemics of Indian origin. Hematology (Amsterdam, Netherlands) 2010;15:174–7.PahujaSPujaniMGuptaSKChandraJJainM.Alloimmunization and red cell autoimmunization in multitransfused thalassemics of Indian origin.2010;15:174–7.10.1179/102453309X1258334711401320557678Search in Google Scholar
Romphruk AV, Simtong P, Butryojantho C, et al. The prevalence, alloimmunization risk factors, antigenic exposure, and evaluation of antigen-matched red blood cells for thalassemia transfusions: a 10-year experience at a tertiary care hospital. Transfusion 2019;59:177–84.RomphrukAVSimtongPButryojanthoC,The prevalence, alloimmunization risk factors, antigenic exposure, and evaluation of antigen-matched red blood cells for thalassemia transfusions: a 10-year experience at a tertiary care hospital.2019;59:177–84.10.1111/trf.1500230443908Search in Google Scholar
Trompeter S, Cohen A, Porter J. Blood transfusion. In: Cappellini MD, Cohen A, Porter J, Taher A, Viprakasit V, Eds. Guidelines for the management of transfusion dependent thalassemia (TDT). 3rd ed. Thalassemia International Federation TIF Publication No. 20; 2014:28–41.TrompeterSCohenAPorterJ.Blood transfusion. In:CappelliniMDCohenAPorterJTaherAViprakasitV, Eds..3rd ed.Thalassemia International Federation TIF PublicationNo.20;2014:28–41.Search in Google Scholar
National Healthcare Safety Network Biovigilance Component Hemovigilance Module Surveillance Protocol v2.5.2. Atlanta, GA: U.S. Centers for Disease Control and Prevention. April 2018.Available from www.cdc.gov/nhsn..Atlanta, GA:U.S. Centers for Disease Control and Prevention.April2018.Available from www.cdc.gov/nhsn.Search in Google Scholar
Matteocci A, Pierelli L. Red blood cell alloimmunization in sickle cell disease and in thalassaemia: current status, future perspectives and potential role of molecular typing. Vox Sanguinis 2014;106:197–208.MatteocciAPierelliL.Red blood cell alloimmunization in sickle cell disease and in thalassaemia: current status, future perspectives and potential role of molecular typing.2014;106:197–208.10.1111/vox.1208624117723Search in Google Scholar
Hendrickson JE, Tormey CA. Understanding red blood cell alloimmunization triggers. Hematology Am Soc Hematol Educ Program. 2016;2016:446–51.HendricksonJETormeyCA.Understanding red blood cell alloimmunization triggers.2016;2016:446–51.10.1182/asheducation-2016.1.446614245727913514Search in Google Scholar
Yazdanbakhsh K, Ware RE, Noizat-Pirenne F. Red blood cell alloimmunization in sickle cell disease: pathophysiology, risk factors, and transfusion management. Blood 2012;120: 528–37.YazdanbakhshKWareRENoizat-PirenneF.Red blood cell alloimmunization in sickle cell disease: pathophysiology, risk factors, and transfusion management.2012;120:528–37.10.1182/blood-2011-11-327361340121322563085Search in Google Scholar
Rujirojindakul P, Flegel WA. Applying molecular immunohaematology to regularly transfused thalassaemic patients in Thailand. Blood Transfus 2014;12:28–35.RujirojindakulPFlegelWA.Applying molecular immunohaematology to regularly transfused thalassaemic patients in Thailand.2014;12:28–35.Search in Google Scholar
Yee MEM, Josephson CD, Winkler AM, et al. Red blood cell minor antigen mismatches during chronic transfusion therapy for sickle cell anemia. Transfusion 2017;57:2738–46.YeeMEMJosephsonCDWinklerAM,Red blood cell minor antigen mismatches during chronic transfusion therapy for sickle cell anemia.2017;57:2738–46.10.1111/trf.14282567353428840600Search in Google Scholar
Cheng CK, Lee CK, Lin CK. Clinically significant red blood cell antibodies in chronically transfused patients: a survey of Chinese thalassemia major patients and literature review. Transfusion 2012;52:2220–4.ChengCKLeeCKLinCK.Clinically significant red blood cell antibodies in chronically transfused patients: a survey of Chinese thalassemia major patients and literature review.2012;52:2220–4.10.1111/j.1537-2995.2012.03570.x22339270Search in Google Scholar
Luban NL. Variability in rates of alloimmunization in different groups of children with sickle cell disease: effect of ethnic background. Am J Pediatr Hematol Oncol 1989;11:314–9.LubanNL.Variability in rates of alloimmunization in different groups of children with sickle cell disease: effect of ethnic background.1989;11:314–9.Search in Google Scholar
Shaz BH, Hillyer CD. Minority donation in the United States: challenges and needs. Current Opin Hematol 2010;17:544–9.ShazBHHillyerCD.Minority donation in the United States: challenges and needs.2010;17:544–9.10.1097/MOH.0b013e32833e5ac7308220220717026Search in Google Scholar